WhichRecall
Class IIReported 2025-08-13

Xolair (omalizumab injection), 75 mg/0.5 ml, Rx only, Genentech, Inc., South San Francisco, CA 94080, NDC 50242-214-55

Recalled by Cardinal Health Inc.

Reason for Recall

CGMP Deviations - Product was exposed to temperatures outside the product's labeled storage requirements.

Advertisement
Recall Number
D-0572-2025
Classification
Class II
Status
Ongoing
Category
drug
Initiated
2025-07-30
Reported
2025-08-13
Distribution
Nationwide Within the U.S.
Code Info
Lot: 3630004, Expires: 10/31/2025.
Source: openFDA enforcement report. WhichRecall is not affiliated with the FDA. See our disclaimer.
Advertisement